These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid. Hussaini SH; Pereira SP; Murphy GM; Kennedy C; Wass JA; Besser GM; Dowling RH Gut; 1995 Jan; 36(1):126-32. PubMed ID: 7890216 [TBL] [Abstract][Full Text] [Related]
3. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Hussaini SH; Murphy GM; Kennedy C; Besser GM; Wass JA; Dowling RH Gastroenterology; 1994 Nov; 107(5):1503-13. PubMed ID: 7926514 [TBL] [Abstract][Full Text] [Related]
8. Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly. A prospective study. Erlinger S; Chanson P; Dumont M; Ponsot P; Warnet A; Harris AG Dig Dis Sci; 1994 Nov; 39(11):2384-8. PubMed ID: 7956607 [TBL] [Abstract][Full Text] [Related]
10. Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones. Hussaini SH; Pereira SP; Veysey MJ; Kennedy C; Jenkins P; Murphy GM; Wass JA; Dowling RH Gut; 1996 May; 38(5):775-83. PubMed ID: 8707128 [TBL] [Abstract][Full Text] [Related]
11. Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly. Turner HE; Lindsell DR; Vadivale A; Thillainayagam AV; Wass JA Eur J Endocrinol; 1999 Dec; 141(6):590-4. PubMed ID: 10601961 [TBL] [Abstract][Full Text] [Related]
12. Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type? Pereira SP; Hussaini SH; Kennedy C; Dowling RH Dig Dis Sci; 1995 Dec; 40(12):2568-75. PubMed ID: 8536514 [TBL] [Abstract][Full Text] [Related]
13. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice. Wang HH; Portincasa P; Wang DQ Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients. Shi YF; Zhu XF; Harris AG; Zhang JX; Dai Q J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099 [TBL] [Abstract][Full Text] [Related]
16. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Ewins DL; Javaid A; Coskeran PB; Shah S; Butler J; Deprez PH; Miell J; Calam J; Barrett JJ; Dawson JM Q J Med; 1992 Apr; 83(300):295-306. PubMed ID: 1631261 [TBL] [Abstract][Full Text] [Related]
17. Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly. Catnach SM; Anderson JV; Fairclough PD; Trembath RC; Wilson PA; Parker E; Besser GM; Wass JA Gut; 1993 Feb; 34(2):270-3. PubMed ID: 8432484 [TBL] [Abstract][Full Text] [Related]
18. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Moschetta A; Stolk MF; Rehfeld JF; Portincasa P; Slee PH; Koppeschaar HP; Van Erpecum KJ; Vanberge-Henegouwen GP Aliment Pharmacol Ther; 2001 Feb; 15(2):181-5. PubMed ID: 11148435 [TBL] [Abstract][Full Text] [Related]
19. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. Kern F; Everson GT; DeMark B; McKinley C; Showalter R; Braverman DZ; Szczepanik-Van Leeuwen P; Klein PD J Lab Clin Med; 1982 Jun; 99(6):798-805. PubMed ID: 7077124 [TBL] [Abstract][Full Text] [Related]